Literature DB >> 8729040

EGF-receptors in human normal and pathological thyroid tissue.

K Westermark1, M Lundqvist, G Wallin, T Dahlman, G W Hacker, N E Heldin, L Grimelius.   

Abstract

Expression of the epidermal growth factor receptor (EGFR) was studied in cryosections from human thyroid tissues. Normal tissue (4 cases), nodular goitre (12), toxic goitre (9), adenoma (9), follicular carcinoma (1), papillary carcinoma (7) and poorly differentiated carcinoma (1) were used for immunohistochemistry. Northern blot analysis was performed in two nodular goitres, three adenomas, two papillary carcinomas, one follicular carcinoma and the adjacent normal tissue in five cases as well as in two cell lines from anaplastic carcinomas. Epidermal growth factor receptor immunoreactivity was detected in all tissues examined. The amount of EGFR mRNA did not differ between normal and abnormal tissues. However, the EGFR staining was weaker in normal thyroid tissue compared to the adjacent neoplastic areas suggesting an upregulation at the posttranslational level in the latter. A strong staining was also seen in hyperfunctioning thyroid glands. The EGFR location was mainly basal or basolateral in all thyroid tissues with normal histology and in toxic diffuse goitre. Pericellular and sometimes cytoplasmatic staining was seen in neoplastic tissues. In nodular goitre the staining was both basal, lateral and apical and varied in intensity. Our data suggest that a non-polarized location of EGFR probably indicates a loss of the normal epithelial cell polarity and could be interpreted as an early sign of dedifferentiation. Furthermore, a role for the EGFR is proposed, not only in the development of thyroid neoplasias but also in goitre formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8729040     DOI: 10.1046/j.1365-2559.1996.d01-427.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Significantly high expression of platelet-derived growth factor (PDGF) in benign nodules of the thyroid: relevance in the development of goitre recurrence?

Authors:  Patrizia Malkomes; Elsie Oppermann; Wolf-Otto Bechstein; Katharina Holzer
Journal:  Langenbecks Arch Surg       Date:  2011-05-08       Impact factor: 3.445

2.  Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.

Authors:  Le Zhao; Xiao-Yun Zhu; Rong Jiang; Man Xu; Ni Wang; George G Chen; Zhi-Min Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas.

Authors:  Debora Degl'Innocenti; Chiara Alberti; Giancarlo Castellano; Angela Greco; Claudia Miranda; Marco A Pierotti; Ettore Seregni; Maria Grazia Borrello; Silvana Canevari; Antonella Tomassetti
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

4.  Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines.

Authors:  Y Nobuhara; N Onoda; Y Yamashita; M Yamasaki; K Ogisawa; T Takashima; T Ishikawa; K Hirakawa
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

5.  Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells.

Authors:  Koichi Ohno; Tomohiro Shibata; Ken-Ichi Ito
Journal:  Cancer Sci       Date:  2022-07-12       Impact factor: 6.518

6.  Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.

Authors:  Hye Sook Min; Chul Lee; Kyeong Cheon Jung
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.